TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983
TCL Archive House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million August 26, 1988
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study May 26, 1995
